Mark Guerin
Direttore Finanziario/CFO presso TRAWS PHARMA, INC.
Patrimonio netto: 22 773 $ in data 30/04/2024
Posizioni attive di Mark Guerin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRAWS PHARMA, INC. | Direttore Finanziario/CFO | 12/02/2016 | - |
| Comptroller/Controller/Auditor | 09/05/2014 | 12/02/2016 | |
| Direttore operativo | 10/06/2022 | 01/04/2024 |
Storia della carriera di Mark Guerin
Precedenti posizioni note di Mark Guerin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Direttore Finanziario/CFO | 01/01/2009 | 01/12/2011 |
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Corporate Officer/Principal | - | - |
Formazione di Mark Guerin
| DeSales University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRAWS PHARMA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Barrier Therapeutics, Inc. discovers, develops, and commercializes pharmaceutical products in the field of dermatology in the United States. It markets Xolegel, Vusion, and Solage gels. The firm markets its products to dermatologists and other target physicians through sales force. The company was founded in 2001 and is headquartered in Princeton, NJ | Health Technology |
- Borsa valori
- Insiders
- Mark Guerin
- Esperienza
